Timothy Eugene Sullivan - 01 Mar 2024 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Signature
/s/s David Watson, attorney-in-fact for Timothy Sullivan
Issuer symbol
APLS
Transactions as of
01 Mar 2024
Net transactions value
-$319,160
Form type
4
Filing time
05 Mar 2024, 16:04:13 UTC
Previous filing
13 Feb 2024
Next filing
02 Apr 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Options Exercise $60,180 +6,000 +6.4% $10.03* 99,338 01 Mar 2024 Direct F2
transaction APLS Common Stock Sale $251,440 -4,000 -4% $62.86 95,338 01 Mar 2024 Direct F2
transaction APLS Common Stock Sale $127,900 -2,000 -2.1% $63.95 93,338 01 Mar 2024 Direct F2
holding APLS Common Stock 56,232 01 Mar 2024 The Timothy E Sullivan Irrevocable Trust of 2023 F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APLS Stock Option (Right to Buy) Options Exercise $0 -6,000 -2.2% $0.000000 261,903 01 Mar 2024 Common Stock 6,000 $10.03 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The securities are held by The Timothy E Sullivan Irrevocable Trust of 2023. Patrick O. Collins is the trustee of The Timothy E Sullivan Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The Timothy E Sullivan Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.
F2 This is a scheduled exercise & sale from 10b5-1 trading plan dated 12/1/23.
F3 This option was granted on October 18, 2017 and fully vested.